Explorations of novel pyridine-pyrimidine hybrid phosphonate derivatives as aurora kinase inhibitors.

MLA

Tiwari, Shailee V., et al. “Explorations of Novel Pyridine-Pyrimidine Hybrid Phosphonate Derivatives as Aurora Kinase Inhibitors.” Bioorganic & Medicinal Chemistry Letters, vol. 67, July 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.bmcl.2022.128747.

APA

Tiwari, S. V., Sarkate, A. P., Lokwani, D. K., Pansare, D. N., Gattani, S. G., Sheaikh, S. S., Jain, S. P., & Bhandari, S. V. (2022). Explorations of novel pyridine-pyrimidine hybrid phosphonate derivatives as aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters, 67, N.PAG. https://doi.org/10.1016/j.bmcl.2022.128747

Chicago

Tiwari, Shailee V., Aniket P. Sarkate, Deepak K. Lokwani, Dattatraya N. Pansare, Surendra G. Gattani, Sameer S. Sheaikh, Shirish P. Jain, and Shashikant V. Bhandari. 2022. “Explorations of Novel Pyridine-Pyrimidine Hybrid Phosphonate Derivatives as Aurora Kinase Inhibitors.” Bioorganic & Medicinal Chemistry Letters 67 (July): N.PAG. doi:10.1016/j.bmcl.2022.128747.